Pharmaceutical Medicine

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Forum
Pharmaceutical Medicine - Tập 31 - Trang 53-67 - 2016
Integrating Genomics into Drug Discovery and Development: Challenges and Aspirations
Pharmaceutical Medicine - Tập 31 - Trang 217-233 - 2017
Rajiv Raja, Young S. Lee, Katie Streicher, James Conway, Song Wu, Sriram Sridhar, Mike Kuziora, Hao Liu, Brandon W. Higgs, Philip Z. Brohawn, Carlos Bais, Bahija Jallal, Koustubh Ranade
Molecular biomarkers are increasingly being used to identify subgroups of patients that have a higher chance of benefiting from targeted therapies. Identification of predictive biomarkers and development of companion diagnostics to accompany targeted agents have been shown to significantly improve the efficacy and approval rate of these novel therapies, making treatment decisions more personalized...... hiện toàn bộ
A Principles Framework for Digital Provision of Medical Information for Healthcare Professionals
Pharmaceutical Medicine - Tập 37 - Trang 103-109 - 2023
Susan Mohamed, Sarah Dunnett, Angela Flores, Eva Loew, Stefne Pienaar
European pharmaceutical companies have a legal requirement to provide non-promotional medical information (MI) services to support healthcare professionals (HCPs) using their medicinal products. While we are seeing an increased HCP preference and expectation towards digital channels, the lack of a compliance framework relating to the provision of non-promotional MI services is a key factor complic...... hiện toàn bộ
The Utility of Active-Controlled Noninferiority/Equivalence Trials in Drug Development
Pharmaceutical Medicine - Tập 21 - Trang 225-233 - 2012
Yi Tsong
Clinical trials designed with the objective of demonstrating that a test treatment is noninferior or equivalent to an active control treatment have long been used in drug development. In general, in order to fulfil the requirement of a New Drug Application, a sponsor needs to conduct randomised clinical trials to demonstrate that the test treatment is effective. With placebo control in the clinica...... hiện toàn bộ
Reliability and Validity of the M-MALMAS Instrument to Assess Medication Adherence in Malay-Speaking Patients with Type 2 Diabetes
Pharmaceutical Medicine - - 2020
Pauline Siew Mei Lai, Renukha Sellappans, Siew Siang Chua
Forum
Pharmaceutical Medicine - Tập 29 - Trang 51-62 - 2015
1st International Congress on Alzheimer’s Disease and Advanced Neurotechnologies
Pharmaceutical Medicine - Tập 24 - Trang 105-108 - 2012
Mary Ellen Kitler
An Overview of Adverse Drug Reaction Monitoring in China
Pharmaceutical Medicine - Tập 20 - Trang 79-85 - 2012
Yibing Zhou, Victor Miller, Matthew Hogan, Larry Callahan
China’s National Center for Adverse Drug Reaction (ADR) Monitoring was established in 1989. In 1998, nearly a decade later, China joined the World Health Organization’s (WHO) Programme for International Drug Monitoring. During March 2004, China formally promulgated the final version of the Regulations on Adverse Drug Reaction Reporting and Monitoring. This modern system supplements an informal rep...... hiện toàn bộ
Where is European Regulation 536/2014 Taking Us?
Pharmaceutical Medicine - - 2023
Anthony W. Fox
Principles and practice of pediatric drug development
Pharmaceutical Medicine - Tập 15 - Trang 5-6 - 2012
Ronald E. Keeney
Tổng số: 876   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10